Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 575

1.

The presence of Aspergillus fumigatus in asthmatic airways is not clearly related to clinical disease severity.

Sullivan A, Hunt EB, Ward C, Lapthorne S, Eustace JA, Fanning LJ, Plant BJ, O'Byrne PM, MacSharry JA, Murphy DM.

Allergy. 2019 Oct 12. doi: 10.1111/all.14087. [Epub ahead of print]

PMID:
31605638
2.

Avoiding missed opportunities to screen for HIV.

OʼByrne P, Orser L.

J Am Assoc Nurse Pract. 2019 Aug 14. doi: 10.1097/JXX.0000000000000274. [Epub ahead of print]

PMID:
31425375
3.

The Global Initiative for Asthma (GINA): 25 years later.

Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O'Byrne PM.

Eur Respir J. 2019 Aug 29;54(2). pii: 1900598. doi: 10.1183/13993003.00598-2019. Print 2019 Aug. Review.

PMID:
31273040
4.

Syphilis.

O'Byrne P, MacPherson P.

BMJ. 2019 Jun 28;365:l4159. doi: 10.1136/bmj.l4159. No abstract available. Erratum in: BMJ. 2019 Jul 19;366:l4746.

5.

Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics.

Revez JA, Bain LM, Watson RM, Towers M, Collins T, Killian KJ, O'Byrne PM, Gauvreau GM, Upham JW, Ferreira MA.

Clin Transl Immunology. 2019 Jun 14;8(6):e1044. doi: 10.1002/cti2.1044. eCollection 2019.

6.

The "Side Effects" of HIV PEP Use: Forced Reflections and Introspections on Sexual Decision-Making.

O'Byrne P, Orser L, Jacob JD.

Res Theory Nurs Pract. 2019 May 1;33(2):196-208. doi: 10.1891/1541-6577.33.2.196.

PMID:
31123163
7.
8.

Asthma progression and mortality: the role of inhaled corticosteroids.

O'Byrne P, Fabbri LM, Pavord ID, Papi A, Petruzzelli S, Lange P.

Eur Respir J. 2019 Jul 18;54(1). pii: 1900491. doi: 10.1183/13993003.00491-2019. Print 2019 Jul. Review.

9.

PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP.

OʼByrne P, MacPherson P, Orser L, Jacob JD, Holmes D.

J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):301-311. doi: 10.1097/JNC.0000000000000075.

10.

Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study.

Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S; PURE investigators.

Lancet Glob Health. 2019 May;7(5):e613-e623. doi: 10.1016/S2214-109X(19)30070-1.

11.

The Evolution of HIV Prevention: From Discipline to Control.

OʼByrne P, Jacob JD.

ANS Adv Nurs Sci. 2019 Oct/Dec;42(4):E1-E10. doi: 10.1097/ANS.0000000000000268.

PMID:
30839336
12.

Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction.

Martin N, Weiler JM, Pearlman D, Jacques L, Nunn C, Forth R, West S, Dunn K, O'Byrne PM.

J Asthma. 2019 Feb 22:1-10. doi: 10.1080/02770903.2019.1579344. [Epub ahead of print]

PMID:
30795705
13.

Rigour after gonorrhea treatment in a 55-year-old man.

O'Byrne P.

Can Fam Physician. 2019 Feb;65(2):112-115. No abstract available.

14.

The interleukin-13 paradox in asthma: effective biology, ineffective biologicals.

Nair P, O'Byrne PM.

Eur Respir J. 2019 Jan 31;53(2). pii: 1802250. doi: 10.1183/13993003.02250-2018. Print 2019 Feb. No abstract available.

PMID:
30760544
15.

Effect of sex on group 2 innate lymphoid cells in the airways of mild and severe asthmatics.

Aw M, Nair P, Salter B, Chen R, Machida K, Inman M, O'Byrne PM, Gauvreau GM, Sehmi R.

Allergy. 2019 Jul;74(7):1397-1400. doi: 10.1111/all.13742. Epub 2019 Feb 26. No abstract available.

PMID:
30741429
16.

Recommended screenings for chlamydia and gonorrhea: A Canadian guidelines review.

OʼByrne P.

Nurse Pract. 2019 Feb;44(2):35-41. doi: 10.1097/01.NPR.0000552681.53898.05.

PMID:
30672865
17.

Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma.

Satia I, Watson R, Scime T, Dockry RJ, Sen S, Ford JW, Mitchell PD, Fowler SJ, Gauvreau GM, O'Byrne PM, Smith JA.

J Allergy Clin Immunol. 2019 Sep;144(3):788-795.e1. doi: 10.1016/j.jaci.2018.11.050. Epub 2019 Jan 17.

PMID:
30660644
18.

Consideration of sexually transmitted infections in the differential diagnosis: Case studies.

OʼByrne P, MacPherson P, Kitson C, Bourgault A.

J Am Assoc Nurse Pract. 2019 Jan;31(1):65-71. doi: 10.1097/JXX.0000000000000103.

PMID:
30624362
19.

Party Drug Use Among Gay Men: Expanding Contemporary Understandings for Nursing Practice.

O'Byrne P.

Res Theory Nurs Pract. 2018 Aug;32(3):296-310. doi: 10.1891/1541-6577.32.3.296.

PMID:
30567840
20.

Population Health and Social Governance: A Review, an Update, Some Clarifications, and a Response.

O'Byrne P.

Qual Health Res. 2019 Apr;29(5):731-738. doi: 10.1177/1049732318815686. Epub 2018 Dec 14.

PMID:
30547724
21.

Methadone maintenance treatment as social control: Analyzing patient experiences.

O'Byrne P, Jeske Pearson C.

Nurs Inq. 2019 Apr;26(2):e12275. doi: 10.1111/nin.12275. Epub 2018 Nov 20.

PMID:
30460726
22.

The role of public health units in the delivery of HIV pre-exposure prophylaxis (PrEP).

Orser L, O'Byrne P.

Can J Public Health. 2019 Feb;110(1):72-75. doi: 10.17269/s41997-018-0141-7. Epub 2018 Oct 19.

PMID:
30341481
23.

Advances in the treatment of mild asthma: recent evidence.

O'Byrne PM, Mejza F.

Pol Arch Intern Med. 2018 Sep 28;128(9):545-549. doi: 10.20452/pamw.4341. Epub 2018 Sep 28. Review.

24.

An Exploratory Study of a Nurse-Led HIV Postexposure Prophylaxis Program.

O'Byrne P, Jacob JD, Orser L.

Policy Polit Nurs Pract. 2018 Feb-May;19(1-2):29-39. doi: 10.1177/1527154418784237. Epub 2018 Jul 9.

PMID:
29986630
25.

Combined Analysis of Asthma Safety Trials of Long-Acting β2-Agonists.

Busse WW, Bateman ED, Caplan AL, Kelly HW, O'Byrne PM, Rabe KF, Chinchilli VM.

N Engl J Med. 2018 Jun 28;378(26):2497-2505. doi: 10.1056/NEJMoa1716868.

26.

Screening for depression: Review of the Patient Health Questionnaire-9 for nurse practitioners.

OʼByrne P, Jacob JD.

J Am Assoc Nurse Pract. 2018 Jul;30(7):406-411. doi: 10.1097/JXX.0000000000000052.

PMID:
29905589
27.

Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.

O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK.

N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274.

28.

As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.

Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM.

N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275.

29.

Expression of IL-33 and TSLP and Their Receptors in Asthmatic Airways after Inhaled Allergen Challenge.

Al-Sajee D, Sehmi R, Hawke TJ, El-Gammal A, Howie KJ, Watson RM, Londei M, Gauvreau GM, O'Byrne PM.

Am J Respir Crit Care Med. 2018 Sep 15;198(6):805-807. doi: 10.1164/rccm.201712-2468LE. No abstract available.

PMID:
29733677
30.

Two pathways, one patient; UK asthma guidelines.

Fowler SJ, O'Byrne PM, Buhl R, Shaw D.

Thorax. 2018 Sep;73(9):797-798. doi: 10.1136/thoraxjnl-2018-211703. Epub 2018 May 3. No abstract available.

PMID:
29724867
31.

Cucurbit[7]uril-Dimethyllysine Recognition in a Model Protein.

Guagnini F, Antonik PM, Rennie ML, O'Byrne P, Khan AR, Pinalli R, Dalcanale E, Crowley PB.

Angew Chem Int Ed Engl. 2018 Jun 11;57(24):7126-7130. doi: 10.1002/anie.201803232. Epub 2018 May 14.

PMID:
29673020
32.

The patient rationale for seeking HIV PEP: Qualitative results from a nurse-led program.

O'Byrne P, Orser L, MacPherson P, Valela N.

Public Health Nurs. 2018 Sep;35(5):386-395. doi: 10.1111/phn.12404. Epub 2018 Apr 6.

PMID:
29633326
33.

Giants in Chest Medicine: Professor Emeritus Elizabeth F. Juniper, MCSP, MSc.

O'Byrne PM.

Chest. 2018 Apr;153(4):776-777. doi: 10.1016/j.chest.2018.01.017. No abstract available.

PMID:
29626968
34.

Nurse-Led HIV PEP Program Used by Men at High Risk for HIV Seroconversion.

O'Byrne P, MacPherson P, Orser L.

J Assoc Nurses AIDS Care. 2018 Jul - Aug;29(4):550-559. doi: 10.1016/j.jana.2018.02.004. Epub 2018 Feb 17.

PMID:
29530543
35.

Interleukin-25 and eosinophils progenitor cell mobilization in allergic asthma.

Tang W, Smith SG, Du W, Gugilla A, Du J, Oliveria JP, Howie K, Salter BM, Gauvreau GM, O'Byrne PM, Sehmi R.

Clin Transl Allergy. 2018 Feb 13;8:5. doi: 10.1186/s13601-018-0190-2. eCollection 2018.

36.

Evolving Concepts in Asthma.

O'Byrne PM.

Semin Respir Crit Care Med. 2018 Feb;39(1):1-2. doi: 10.1055/s-0037-1620250. Epub 2018 Feb 10. No abstract available.

PMID:
29427979
37.

The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.

Gauvreau GM, FitzGerald JM, Boulet LP, Watson RM, Hui L, Villineuve H, Scime TX, Schlatman AR, Obminski C, Kum J, Boehme S, Ly TW, Bacon KB, O'Byrne PM.

Clin Exp Allergy. 2018 Apr;48(4):445-451. doi: 10.1111/cea.13114. Epub 2018 Mar 13.

PMID:
29423947
38.

Overfilled urine specimens for gonorrhea and chlamydia testing: Implications for practice.

O'Byrne P, Orser L.

Appl Nurs Res. 2018 Feb;39:121-124. doi: 10.1016/j.apnr.2017.11.014. Epub 2017 Nov 6.

PMID:
29422146
39.

Sputum cytology during late-phase responses to inhalation challenge with different allergens.

Revez JA, Killian KJ, O'Byrne PM, Boulet LP, Upham JW, Gauvreau GM, Ferreira MAR.

Allergy. 2018 Jul;73(7):1470-1478. doi: 10.1111/all.13415. Epub 2018 Feb 6.

PMID:
29337345
40.

Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy.

Byrne CJ, Parton T, McWhinney B, Fennell JP, O'Byrne P, Deasy E, Egan S, Enright H, Desmond R, Ryder SA, D'Arcy DM, McHugh J, Roberts JA.

J Antimicrob Chemother. 2018 Apr 1;73(4):995-1003. doi: 10.1093/jac/dkx473.

PMID:
29272419
41.

Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge.

Oliveria JP, El-Gammal AI, Yee M, Obminski CD, Scime TX, Watson RM, Howie K, O'Byrne PM, Sehmi R, Gauvreau GM.

J Allergy Clin Immunol. 2018 Apr;141(4):1495-1498.e9. doi: 10.1016/j.jaci.2017.11.013. Epub 2017 Dec 6. No abstract available.

42.

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.

Tan DHS, Hull MW, Yoong D, Tremblay C, O'Byrne P, Thomas R, Kille J, Baril JG, Cox J, Giguere P, Harris M, Hughes C, MacPherson P, O'Donnell S, Reimer J, Singh A, Barrett L, Bogoch I, Jollimore J, Lambert G, Lebouche B, Metz G, Rogers T, Shafran S; Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network.

CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494. No abstract available. Erratum in: CMAJ. 2018 Jun 25;190(25):E782.

43.

Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response.

Singh A, Shannon CP, Kim YW, Yang CX, Balshaw R, Cohen Freue GV, Gauvreau GM, FitzGerald JM, Boulet LP, O'Byrne PM, Tebbutt SJ.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):450-462. doi: 10.1164/rccm.201701-0110OC.

PMID:
29087730
44.

The paradoxes of asthma management: time for a new approach?

O'Byrne PM, Jenkins C, Bateman ED.

Eur Respir J. 2017 Sep 9;50(3). pii: 1701103. doi: 10.1183/13993003.01103-2017. Print 2017 Sep. Review.

45.

Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer.

Blais CM, Cockcroft DW, Veilleux J, Boulay MÈ, Boulet LP, Gauvreau GM, Scime TX, Watson RM, O'Byrne PM, Davis BE.

J Aerosol Med Pulm Drug Deliv. 2018 Apr;31(2):88-93. doi: 10.1089/jamp.2017.1392. Epub 2017 Aug 16.

PMID:
28813613
46.

Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis.

Djukanovic R, O'Byrne PM.

N Engl J Med. 2017 May 18;376(20):1985-1986. doi: 10.1056/NEJMe1704402. No abstract available.

PMID:
28514619
47.

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment.

Jenkins CR, Eriksson G, Bateman ED, Reddel HK, Sears MR, Lindberg M, O'Byrne PM.

BMC Pulm Med. 2017 Apr 20;17(1):65. doi: 10.1186/s12890-017-0401-y.

48.

Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma.

Chen R, Smith SG, Salter B, El-Gammal A, Oliveria JP, Obminski C, Watson R, O'Byrne PM, Gauvreau GM, Sehmi R.

Am J Respir Crit Care Med. 2017 Sep 15;196(6):700-712. doi: 10.1164/rccm.201612-2427OC.

PMID:
28422515
49.

Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy.

Byrne CJ, Roberts JA, McWhinney B, Fennell JP, O'Byrne P, Deasy E, Egan S, Desmond R, Enright H, Ryder SA, D'Arcy DM, McHugh J.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02466-16. doi: 10.1128/AAC.02466-16. Print 2017 Jun.

50.

The Potential Role of Aspiration in the Asthmatic Airway.

Hunt EB, Ward C, Power S, Sullivan A, Pearson JP, Lapthorne S, O'Byrne PM, Eustace J, Plant BJ, Maher MM, MacSharry J, Murphy DM.

Chest. 2017 Jun;151(6):1272-1278. doi: 10.1016/j.chest.2017.03.005. Epub 2017 Mar 11.

PMID:
28300572

Supplemental Content

Loading ...
Support Center